Caltag is delighted to be sponsoring The BACR’s Tumour Microenvironment meeting and 3D Cancer Modelling workshop on 8 – 10 July 2026!
BACR Tumour Microenvironment Meeting and 3D Cancer Modelling Workshop
Cancer Research Tools by Caltag Medsystems
With 1 person dying of cancer every 4 minutes, there is a need for more research. Explore our cancer research products to help change these statistics.
AMP-activated protein kinase (AMPK) Role in Cancer and Metabolic Diseases
MBL International’s AMPK kinase assay kit can be used to measure the activity of AMPK, a cellular energy sensor.
Cervical cancer is the fourth most common cancer affecting women: Antigen-Specific Detection of HPV and HSV
Cervical cancer is the 4th most prevalent cancer among women, and the 7th most common cancer. MBLI provides HPV-related tetramers for use in research.
Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy
Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.
Discover the Ab-Match ELISA Series: Unveiling Cancer Biomarkers and Beyond
The Ab-Match series by MBL are innovative ELISA kits for the detection of cancer antigens. These convenient kits come with all the necessary components for successful detection.
Monoclonal Antibody Drugs for Cancer
Monoclonal antibody drugs have emerged as powerful tools in the fight against cancer, revolutionising treatment approaches.
PD-1: Expanding Beyond Cancer Research
ProSci details the importance of PD-1 antibodies are important in resolving complex interactions between the immune system & pathological conditions.
Evaluating the biological activity of a cancer vaccine with the HLA-A*02:01 QuickSwitch™ Quant platform
Principle of the cell-based T2 shift assay and the cell-free QuickSwitch™ Quant assay Comparison of the cell-based T2 shift assay and the cell-free QuickSwitch™ Quant assay Immuno-oncology is a growing field in which different strategies such as immune modulators, vaccines
Cancer Immunotherapy: A Colourful Past and A Bright Future
cancer_immunotherapy Cancer immunotherapy is one promising cancer treatment option whereby the host’s own immune system is used to treat cancer. The therapy works by either stimulating certain immune activities, or counteracting cancer cell signals that suppress immune